Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide

Nature Medicine

Volumn 3, Issue 8, 1997, Pages 900-903

  Suzuki, Jun Ichi ^a   Isobe, Mitsuaki ^a   Morishita, Ryuichi ^b   Aoki, Motokuni ^b   Horie, Shiro ^a   Okubo, Yoshio ^a   Kaneda, Yasufumi ^b   Sawa, Yoshiki ^b   Matsuda, Hikaru ^b   Ogihara, Toshio ^b   Sekiguchi, Morie ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFECT; DRUG SCREENING; GENE TRANSFER; HEART TRANSPLANTATION; MALE; MOUSE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CDC2-CDC28 KINASES; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRAFT VS HOST DISEASE; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN-SERINE-THREONINE KINASES; RESPIROVIRUS; RNA, MESSENGER;

ANIMALIA; MURINAE;

EID: 0030877852     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0897-900     Document Type: Article

References (20)

1. Hosenpud, J.D., Novick, R.J., Breen, T.J., Berkeley, K. & Daily, O.P. The registry of the international society for heart and lung transplantation: Twelfth official report, 1995. J. Heart Lung Transplant. 11, 805-815 (1995).
2. Botas, J. et al. Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy: An intravascular ultrasound study. Circulation 92, 1126-1132 (1995).
3. Suzuki, J. et al. Nonmuscle and smooth muscle myosin heavy chain expression in rejected cardiac allografts: A study in rat and monkey models. Circulation 94, 1118-1124 (1996).
4. Hosenpud, J.D. Immune mechanism of cardiac allograft vasculopathy: An update. Transplant. Immunology 1, 237-249 (1993).
5. Pollak, R. & Fabrega, A.J. Diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N. Engl. J. Med. 328, 1851-1852 (1993).
6. Larsen, C.P. et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438 (1996).
7. Furukawa, Y., Matsumori, A., Hirozane, T. & Sasayama, S. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model: A comparative study with captopril. Circulation 93, 333-339 (1996).
8. Pagano, M., Draetta, G. & Durr, J. Association of cdk 2 kinase with the transcription factor E2F during S phase. Science 255, 1144-1147 (1992).
9. Tsai, L.H., Harlow, E. & Meyerson, M. Isolation of the human cdk2 gene that encodes the cycline A and adenovirus E1A associated p33 kinase. Nature 353, 174-177 (1991).
10. Koff, A., Otsuki, M., Polyak, K., Roberts, J.M. & Massague, J. Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-beta. Science 260, 536-539 (1993).
11. Morishita, R. et al. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J. Clin. Invest. 93, 1458-1464 (1994).
12. Morishita, R. et al. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc. Natl. Acad. Sci. USA 90, 8474-8478 (1993).
13. Kaneda, Y., Iwai, K. & Uchida, T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243, 375-378 (1989).
14. Nuovo, G.J., Gallery, F., MacConnell, P. & Braun, A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am. J. Pathol. 144, 659-666 (1994).
15. Sawa, Y. et al. Efficiency of in vivo gene transfection into transplanted rat heart by coronary infusion of HVJ liposome. Circulation 92 (Suppl. 2), 479-482 (1995).
16. Dzau, VJ., Mann, MJ., Morishita, R. & Kaneda, Y. Fusigenic viral liposome for gene therapy in cardiovascular diseases. Proc. Natl. Acad. Sci. USA 93, 11421-11425 (1996).
17. Isobe, M., Yagita, H., Okumura, K. & Ihara, A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255, 1125-1127 (1992).
18. Suzuki, J. et al. Inhibition of accelerated coronary atherosclerosis with short-term blockade of ICAM-1 and LFA-1 in the heterotopic murine model of cardiac transplantation. J. Heart Lung Transplant, (in the press).
19. Eich, D.M. et al. Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation. Circulation 87, 261-269 (1993).
20. Cybulsky, M.I. & Gimbrone, M.A., Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788-791 (1991).